This week’s MedTech tracker showcases the intersection of AI and neurotechnology, with investors backing companies advancing stroke imaging, neurotherapeutics, wearable biosensors, and neuromuscular interfaces. Capital is flowing toward U.S. expansion, regulatory milestones, and platform-scale...
This week’s MedTech tracker showcases the intersection of AI and neurotechnology, with investors backing companies advancing stroke imaging, neurotherapeutics, wearable biosensors, and neuromuscular interfaces....
TECLens has commenced the first-in-human clinical trial assessing its quantitative corneal crosslinking (qCXL) technology for non-invasive refractive vision correction, administering treatment to the initial...
Blue Arbor Technologies announced a partnership with Ottobock, anchored by a $5 million investment.
The investment positions Ottobock — also the leading shareholder in Onward...
Trinity Biotech announced that it entered into a $25 million Standby Equity Purchase Agreement (SEPA).
The agreement with an affiliate of financing partner Yorkville Advisors...
TECLens has commenced the first-in-human clinical trial assessing its quantitative corneal crosslinking (qCXL) technology for non-invasive refractive vision correction, administering treatment to the initial...
VESTECK announced that implanting clinicians will present two-year follow-up data from the company’s first-in-human experience with the SUTURE-TIGHT™ Endovascular Catheter System, an adjunctive fixation...
Kandu Health announced positive results from the first randomized controlled trial of its brain-computer interface (BCI) therapy.
The trial evaluated its FDA-cleared, non-invasive IpsiHand BCI...
CorTec GmbH, a pioneer in active implantable medical technologies, announced the successful second implantation of its proprietary BrainComputer Interface (BCI) system, the Brain Interchange,...
This week’s MedTech tracker showcases the intersection of AI and neurotechnology, with investors backing companies advancing stroke imaging, neurotherapeutics, wearable biosensors, and neuromuscular interfaces....
TECLens has commenced the first-in-human clinical trial assessing its quantitative corneal crosslinking (qCXL) technology for non-invasive refractive vision correction, administering treatment to the initial...
Blue Arbor Technologies announced a partnership with Ottobock, anchored by a $5 million investment.
The investment positions Ottobock — also the leading shareholder in Onward...
Trinity Biotech announced that it entered into a $25 million Standby Equity Purchase Agreement (SEPA).
The agreement with an affiliate of financing partner Yorkville Advisors...